These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4483042)

  • 41. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. II. Whole-blood amino-acid and fluorescent-antibody studies following immunization.
    Feigin RD; Jaeger RF; McKinney RW; Alevizatos AC
    Am J Trop Med Hyg; 1967 Nov; 16(6):769-77. PubMed ID: 4864056
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of multiagency coordination in dealing with epizootics of zoonoses.
    Saulmon EE
    J Am Vet Med Assoc; 1972 Dec; 161(11):1520-3. PubMed ID: 4674084
    [No Abstract]   [Full Text] [Related]  

  • 45. Serologic responses to eastern and western equine encephalomyelitis vaccination in previously vaccinated horses.
    Waldridge BM; Wenzel JG; Ellis AC; Rowe-Morton SE; Bridges ER; D'Andrea G; Wint R
    Vet Ther; 2003; 4(3):242-8. PubMed ID: 15136985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An educational campaign for mosquito control in Lexington, Massachusetts.
    Smith GA
    J Am Mosq Control Assoc; 1986 Mar; 2(1):97-8. PubMed ID: 3507482
    [No Abstract]   [Full Text] [Related]  

  • 48. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
    Turell MJ; O'Guinn ML; Parker MD
    Am J Trop Med Hyg; 2003 Feb; 68(2):218-21. PubMed ID: 12641414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central nervous system response of horses to Venezuelan equine encephalomyelitis vaccine (TC-83).
    Monlux WS; Luedke AJ; Bowne J
    J Am Vet Med Assoc; 1972 Aug; 161(3):265-9. PubMed ID: 5042953
    [No Abstract]   [Full Text] [Related]  

  • 51. Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man.
    Alevizatos AC; McKinney RW; Feigin RD
    Am J Trop Med Hyg; 1967 Nov; 16(6):762-8. PubMed ID: 6066224
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin.
    Barton MH; Moore JN; Norton N
    Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Definitive efficacy and safety testing for equine encephalomyelitis vaccine.
    Hays MB
    J Am Vet Med Assoc; 1969 Jul; 155(2):374-6. PubMed ID: 5816120
    [No Abstract]   [Full Text] [Related]  

  • 54. Serial passages of equine infectious anemia virus in horse leukocyte culture.
    Kobayashi K; Kono Y
    Natl Inst Anim Health Q (Tokyo); 1967; 7(1):1-7. PubMed ID: 4293211
    [No Abstract]   [Full Text] [Related]  

  • 55. SIMULTANEOUS AEROSOL IMMUNIZATION OF MONKEYS WITH LIVE TULAREMIA AND LIVE VENEZUELAN EQUINE ENCEPHALOMYELITIS VACCINES.
    SAWYER WD; KUEHNE RW; GOCHENOUR WS
    Mil Med; 1964 Nov; 129():1040-3. PubMed ID: 14200847
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunity to bivalent tissue culture origin equine encephalomyelitis vaccine.
    Gutekunst DE
    J Am Vet Med Assoc; 1969 Jul; 155(2):368-74. PubMed ID: 5816119
    [No Abstract]   [Full Text] [Related]  

  • 57. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Observations on vaccine and post-infection immunity in contagious equine metritis.
    Fernie DS; Batty I; Walker PD; Platt H; Mackintosh ME; Simpson DJ
    Res Vet Sci; 1980 May; 28(3):362-7. PubMed ID: 7414090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
    Turell MJ; Parker MD
    Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Western encephalomyelitis in Manitoba during 1975: summary and recommendations.
    Sekla LH
    Can J Public Health; 1976; 67 Suppl 1():74-5. PubMed ID: 963663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.